Dr. Michael Hwang

Dr. Michael Hwang, MD, is a board-certified medical oncologist specializing in the care of patients with head and neck cancer. He serves as a physician at Memorial Sloan Kettering Commack and Memorial Sloan Kettering Nassau, where he delivers expert cancer care to the central and eastern Long Island community. Dr. Hwang completed his undergraduate studies in biology at Cornell University and earned his MD from Rutgers New Jersey Medical School. He went on to complete his residency in internal medicine at the Icahn School of Medicine at Mount Sinai Hospital and his fellowship in medical oncology at the Sidney Kimmel Comprehensive Cancer Center of the Johns Hopkins School of Medicine. Prior to joining MSK, he served as an Assistant Professor in the Upper Aerodigestive Department at Johns Hopkins Hospital, where he specialized in the treatment of head and neck cancers.

Dr. Hwang is focused on providing innovative, evidence-based care and bringing clinical trials closer to patients' homes and communities. He works to develop personalized treatment plans for each patient through both standard and emerging approaches, reflecting his commitment to incorporating the latest advances in oncology into everyday clinical practice. His work in head and neck cancer is deeply personal, rooted in his father's own experience with the disease, which first drew him to oncology and shaped his understanding of the profound impact that a skilled, compassionate physician can have on patients and their families.

Central to Dr. Hwang's practice is the belief that each patient's journey with cancer is unique. He is dedicated to walking alongside patients and their caregivers from the time of diagnosis through treatment and beyond, offering support, guidance, and individualized care at every step. His approach combines clinical rigor with patience, compassion, and understanding, values he first witnessed in his father's oncologist and has carried with him throughout his career. Through his work at MSK's Long Island locations, he strives to make high-quality, personalized cancer care accessible to the communities he serves.